[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4397 followers Created: 2025-06-12 10:30:12 UTC $APLT Appointments: On June 9, 2025, Applied Therapeutics, Inc. held its Annual Meeting where stockholders elected a new director, ratified Ernst & Young as auditors, approved executive compensation, chose to hold future votes annually, and approved a stock consolidation plan ranging from 1-for-5 to 1-for-40. The meeting reflected active shareholder engagement and governance decisions. XXX engagements  **Related Topics** [governance](/topic/governance) [$aplt](/topic/$aplt) [sec](/topic/sec) [Post Link](https://x.com/USCorpFilings/status/1933109574367690883)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
SEC Filings Digest @USCorpFilings on x 4397 followers
Created: 2025-06-12 10:30:12 UTC
$APLT Appointments:
On June 9, 2025, Applied Therapeutics, Inc. held its Annual Meeting where stockholders elected a new director, ratified Ernst & Young as auditors, approved executive compensation, chose to hold future votes annually, and approved a stock consolidation plan ranging from 1-for-5 to 1-for-40. The meeting reflected active shareholder engagement and governance decisions.
XXX engagements
Related Topics governance $aplt sec
/post/tweet::1933109574367690883